Highlights
A collection of news and information related to Novartis AG published by this site and its partners.
Displaying items 1-12 of 58
» View herald-mail.com items only
1
2
3
4
5
•
Next >
-
Kareem Abdul-Jabbar continues to promote a healthy, active lifestyle
Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...Tags: Leukemia, Kobe Bryant, Jimmy Kimmel, National Basketball Association, Lymphoma
-
Indian court ruling hailed as victory for generic drugs
The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...
Tags: Leukemia, India, Trade Agreements, Drugs and Medicines, U.S. Chamber of Commerce
-
Drug maker Novartis loses India patent battle
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...
Tags: Leukemia, Health Treatments, India, HIV Treatment, HIV
-
10 Things to Know for Today
Your daily look at late-breaking news, upcoming events and the stories that will be talked about today: 1. TEXAS DA'S DEATH PUTS PROSECUTORS ON ALERT Law enforcement is beefing up security for Texas district attorneys after Mike McLelland and his wife...Tags: James Holmes
-
An insider's view of generic-drug pricing
Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers. When it comes to patented name-brand drugs, he told me,...
Tags: India, Prescription Drugs, High Blood Pressure, Science and Technology, Patents, Copyrights and Trademarks
-
Swiss voters say yes to 'Rip-Off Initiative' to control executive pay
Voters in Switzerland, angered by high executive pay, backed a plan to increase the control of shareholders over compensation of corporate leaders. Nearly 70% of voters approved the so-called "Rip-Off Initiative," according to the Swiss television...
Tags: Punishment, Television Industry, Elections, Television Stations, CEO Pay
-
Asthma drug calms chronic hives, rashes
Sufferers of chronic hives and rashes could benefit from a commonly-used asthma drug, Johns Hopkins researchers have found. Scientists found that a once-a-month dose of the drug omalizumab helped ease symptoms that standard antihistamines didn't....Tags: Asthma, Medical Research, Symptoms, Genentech Inc., Skin Rash
-
Corporations and execs need penalties that hurt
If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...
Tags: Court Preliminary, Punishment, Bank of America Corp., Fines, Crime, Law and Justice
-
CEO of Strategic Thinking Institute grasped value while watching operation
Special to the TribuneA dozen managers sat around a rectangular table at the Wit hotel in the Loop, their attention fixed on a man in an Armani suit standing in the front of the room. They waited quietly, the CTA Red Line train periodically rumbling by, until the tall,...Tags: Chicago Transit Authority, Companies and Corporations, DePaul University, Conservation, Google Inc.
-
Novartis patent case in India seen as crucial for generic drugs
World NowThe Indian Supreme Court is slated Wednesday to take up a case that aid agencies warn could have sweeping effects on medicine for the global poor, the culmination of a lengthy legal battle between a Swiss drug company and a country known as a mecca for... -
Greek leader pleads for more time to implement reforms
World NowGreek Prime Minister Antonis Samaras launched a high-gear diplomatic offensive aimed at buying his country more time to implement reforms demanded by increasingly impatient European creditors....
Oct 25, 2011
|Story| AP Member Choice Complete
Apr 12, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Los Angeles Times
Mar 31, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Aberdeen News
Mar 25, 2013
|Column| Los Angeles Times
Mar 4, 2013
|Story| Los Angeles Times
Mar 3, 2013
|Story| Baltimore Sun
Jan 5, 2013
|Column| Los Angeles Times
Aug 20, 2012
|Story| Chicago Tribune
Aug 22, 2012
| Los Angeles Times
Aug 22, 2012
| Los Angeles Times
Original site for Novartis AG topic gallery.